A pharmacy tech holds a bottle and a pill of Hydroxychloroquine at Rock Canyon Pharmacy in Provo, Utah, on May 20, 2020.
The World Health Organization has halted research on whether hydroxychloroquine could be an effective treatment for COVID-19.
Multiple studies have shown that the drug, an anti-malarial medicine also used to treat lupus and rheumatoid arthritis, has no impact on the coronavirus.
The WHO said in a statement Wednesday that recent findings "showed that hydroxychloroquine does not result in the reduction of mortality of hospitalized COVID-19 patients."
The decision will not affect other research examining whether hydroxychloroquine might be beneficial to prevent COVID-19 or for patients after they recover from the virus.
